These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31757648)

  • 1. Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population.
    Selmi C; De Santis M; Battezzati PM; Generali E; Lari SA; Ceribelli A; Isailovic N; Zermiani P; Neidhöfer S; Matthias T; Scirè CA; Baldassarre D; Zuin M
    Int J Cardiol; 2020 Feb; 300():209-213. PubMed ID: 31757648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
    Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction.
    Dropiński J; Szczeklik W; Rubiś P; Sydor WJ
    Med Sci Monit; 2003 Apr; 9(4):BR105-9. PubMed ID: 12709660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subclinical Atherosclerosis in Patients with Antiphospholipid Syndrome and Subjects With Antiphospholipid Antibody Positivity: A Systematic Review and Meta-analysis.
    Karakasis P; Lefkou E; Pamporis K; Nevras V; Bougioukas KI; Haidich AB; Fragakis N
    Curr Probl Cardiol; 2023 Jun; 48(6):101672. PubMed ID: 36841314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort.
    Lin H; Ding Y; Ning C; Qiao X; Chen X; Chen X; Shen W; Liu X; Hong Y; He N
    Lancet HIV; 2019 Dec; 6(12):e860-e868. PubMed ID: 31635991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-phospholipid antibody syndrome occurrence in patients with persistent anti-phospholipid antibodies.
    Choi H; Ahn SS; Song JJ; Park YB; Song J; Lee SW
    Rheumatol Int; 2019 Aug; 39(8):1359-1367. PubMed ID: 31076830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
    Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
    Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
    Ruscitti P; Margiotta DPE; Macaluso F; Iacono D; D'Onofrio F; Emmi G; Atzeni F; Prete M; Perosa F; Sarzi-Puttini P; Emmi L; Cantatore FP; Triolo G; Afeltra A; Giacomelli R; Valentini G
    Medicine (Baltimore); 2017 Oct; 96(42):e8180. PubMed ID: 29049200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study.
    Di Minno MND; Emmi G; Ambrosino P; Scalera A; Tufano A; Cafaro G; Peluso R; Bettiol A; Di Scala G; Silvestri E; Prisco D
    Int J Cardiol; 2019 Jan; 274():1-6. PubMed ID: 30454720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between common carotid artery diameter, Framingham risk score and cardiovascular events.
    Kozakova M; Morizzo C; La Carrubba S; Fabiani I; Della Latta D; Jamagidze J; Chiappino D; Di Bello V; Palombo C
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):329-334. PubMed ID: 28242234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
    De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
    Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Subclinical Carotid Atherosclerosis and Role of Cardiovascular Risk Factors in Older Adults: Atherosclerosis and Aging are Not Synonyms.
    Spannella F; Di Pentima C; Giulietti F; Buscarini S; Ristori L; Giordano P; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Jun; 27(3):231-238. PubMed ID: 32219668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β
    Serrano M; Martínez-Flores JA; Pérez D; García F; Cabrera-Marante O; Pleguezuelo D; Paz-Artal E; Morales JM; González E; Serrano A
    Circulation; 2017 May; 135(20):1922-1934. PubMed ID: 28249878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
    Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
    Front Immunol; 2018; 9():2457. PubMed ID: 30464761
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.
    Charakida M; Besler C; Batuca JR; Sangle S; Marques S; Sousa M; Wang G; Tousoulis D; Delgado Alves J; Loukogeorgakis SP; Mackworth-Young C; D'Cruz D; Luscher T; Landmesser U; Deanfield JE
    JAMA; 2009 Sep; 302(11):1210-7. PubMed ID: 19755700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.